Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk.  Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
31 - 40 of 178 search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk

  1. Fully-matching results

  2. KARPAS 25 Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/
    Thumbnail for KARPAS 25 Human Myeloma cell line 9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

  3. Impact Insight video case study: Xampla – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-xampla/
    Thumbnail for Impact Insight video case study: Xampla – Cambridge Enterprise 15 Mar 2022: The first in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Xampla.

  4. Research tools licensing – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/research-tools/
    19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.

  5. Impact Insight: Versed AI – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-versed-ai/
    Thumbnail for Impact Insight: Versed AI – Cambridge Enterprise 12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation

  6. KARPAS 417 Human Myeloma cell line

    https://www.enterprise.cam.ac.uk/reagents/karpas-417-human-myeloma-cell-line/
    Thumbnail for KARPAS 417 Human Myeloma cell line 9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

  7. TenU receives £4 million to boost research commercialisation –…

    https://www.enterprise.cam.ac.uk/news/tenu-receives-4-million-to-boost-research-commercialisation/
    Thumbnail for TenU receives £4 million to boost research commercialisation – Cambridge Enterprise 18 Aug 2022: International research commercialisation collaboration TenU receives £4m funding boost

  8. Impact Insight video case study: iKVA – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-ikva/
    Thumbnail for Impact Insight video case study: iKVA – Cambridge Enterprise 23 Mar 2022: The story behind the creation of iKVA, a University of Cambridge spin-out that uses AI to facilitate knowledge management for multinationals.

  9. Impact Insight: Kalamna CIC – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/video/impact-insight-kalamna-cic/
    Thumbnail for Impact Insight: Kalamna CIC – Cambridge Enterprise 12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Kalamna CIC. Share:. Impact Insight video case study: Kalamna toolkit. The third in our Impact Insight video series focuses on the licensing of the Kalamna toolkit for

  10. KARPAS 929 Human Myeloma cell line - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/karpas-929-human-myeloma-cell-line/
    Thumbnail for KARPAS 929 Human Myeloma cell line - Cambridge Enterprise 9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research.

  11. £1.5m seed funding for Cambridge spin-out iKVA – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/university-of-cambridge-spin-out-ikva-secures-1-5m-seed-funding/
    Thumbnail for £1.5m seed funding for Cambridge spin-out iKVA – Cambridge Enterprise 2 Feb 2022: University of Cambridge spin-out iKVA has secured £1.5m in seed funding to begin the rollout of its unique AI technology.

Refine your results

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.